Oncology Today with Dr Neil Love

348 Episodo

1. Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

   Publicado: 20/5/2024
2. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

   Publicado: 13/5/2024
3. Virtual Case Library: Metastatic Triple-Negative Breast Cancer

   Publicado: 8/5/2024
4. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

   Publicado: 6/5/2024
5. Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

   Publicado: 3/5/2024
6. Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

   Publicado: 1/5/2024
7. Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

   Publicado: 26/4/2024
8. Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

   Publicado: 24/4/2024
9. Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

   Publicado: 23/4/2024
10. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

    Publicado: 15/4/2024
11. Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Publicado: 12/4/2024
12. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

    Publicado: 5/4/2024
13. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

    Publicado: 5/4/2024
14. The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Publicado: 3/4/2024
15. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

    Publicado: 27/3/2024
16. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Publicado: 26/3/2024
17. Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

    Publicado: 25/3/2024
18. Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

    Publicado: 21/3/2024
19. Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Publicado: 19/3/2024
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

    Publicado: 15/3/2024